STEERLife Collaborates with the University of Mississippi
STEERLife and the University of Mississippi will collaborate on fractional lobe processing research.On Nov, 15, 2016 STEERLife, creator of proprietary continuous processing technology, and the University of Mississippi, announced an agreement for collaborative research using fractional lobe processing. The agreement is for the development of advanced pharmaceutical applications including semisolid formulations for dermal and transdermal applications.
STEERLife and the University of Mississippi will collaborate on fractional lobe processing research.
On Nov, 15, 2016 STEERLife, creator of proprietary continuous processing technology, and the University of Mississippi, announced an agreement for collaborative research using fractional lobe processing. The agreement is for the development of advanced pharmaceutical applications including semisolid formulations for dermal and transdermal applications.
Under the terms of the agreement, STEERLife will invest over a period of four years. STEERLife will provide the proprietary co-rotating twin screw technology platform and equipment with fractional lobe technology and training in use of the technology, and the company will sponsor a doctoral research program. The partnership will also engage students pursuing their Masters, Doctoral, and Postdoctoral studies on research-based projects. S.Narasimha Murthy, professor of Pharmaceutics and Drug Delivery at the University's School of Pharmacy, will be the principal investigator, and Michael Repka, professor and chair of Department of Pharmaceutics and Drug Delivery, will be the co-investigator of this research project.
Source: STEERLife
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
